Back to NewsPublished: 20 Jan 2026Download AppJoin TelegramSun Pharma's $10B Organon Bid: Opportunity or Overreach for Indian Pharma?#Sun Pharma#Organon#Pharma M&A#Biosimilars#Investing#IndiaDownload AppJoin CommunityShare Article